SCHEMBL13797023

SCHEMBL13797023

NNc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc(Cl)c3)CC2)nc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 12/20 0.60
▸ SLC6A4 P31645 2/20 0.60
▸ AQP1 P29972 2/20 0.56
▸ ADRA2A P08913 4/20 0.55
▸ MCHR1 Q99705 3/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ NPY1R P25929 1/20 0.55
▸ NPY2R P49146 1/20 0.55
▸ NPY4R P50391 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ SOS1 Q07889 2/20 0.46
▸ GBA1 P04062 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ FBP1 P09467 1/20 0.44
▸ GPR39 O43194 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13796953 0.93 NPY5R (0.60) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796991 0.93 NPY5R (0.59) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13795716 0.91 NPY5R (0.58) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796439 0.90 NPY5R (0.57) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796950 0.90 NPY5R (0.57) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13795923 0.89 NPY5R (0.56) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796242 0.88 NPY5R (0.55) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796928 0.88 NPY5R (0.55) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13796997 0.87 NPY5R (0.79) NPY5RSLC6A4AQP1ADRA2AMCHR1
SCHEMBL13793250 0.84 NPY5R (0.69) NPY5RSLC6A4AQP1ADRA2AMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544690-B2 MCH receptor antagonists TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-06-09 — — US disclosed
Send feedback